Stephen J. Mcandrew

Stephen J. Mcandrew has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Outlook Therapeutics, Inc. and Sonnet BioTherapeutics Holdings, Inc. In total, 7 filings cover trades dated from 9 November 2016 to 2 December 2025.

Every open-market trade on record is a sale: 2 sales worth €89k. Besides market trades, the filings include 2 share grants and 1 option exercise.

The latest filing, published on 3 December 2025, reports a transaction in Sonnet BioTherapeutics Holdings, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.